Loading
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Sept 2026 for Anixa Biosciences Inc, €12k. Read the official filing
Filing timeline
BuySaleArnold M. Baskies
Insider track record
Disclosed buys
9
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
+7.3%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Arnold M. Baskies: trading record in brief
This profile gathers the share dealings of Arnold M. Baskies across 2 companies, led by Anixa Biosciences Inc and Baudax Bio, Inc. The record holds 12 filings, for trades running from 11 May 2021 to 24 September 2026.
On the market, this insider has only ever bought: 9 purchases, €256k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants and 1 option exercise. Since January 2026: 2 purchases and no sales on the market.
A typical purchase (the median) is worth €15k. Clusters matter here: 7 out of 9 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 28 September 2026, reports an open-market purchase of €12k in Anixa Biosciences Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Arnold M. Baskies
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
5,000 shares@ US$2.76Common StockSEC:0001493152-26-044457:0
Canonical exit: 23 Dec 2026 (T+90)
5,428 shares@ US$3.460.020% mcap6.1% of flowCommon StockSEC:0001493152-26-035122:1
6,000 shares@ US$3.130.020% mcap6.1% of flowCommon StockSEC:0001493152-26-035122:0
10,000 shares@ US$3.049.4% of flowCommon StockSEC:0001493152-26-004148:0
Canonical exit: 28 Apr 2026 (T+90)
5,000 shares@ US$3.395.4% of flowCommon StockSEC:0001641172-25-020362:0
Canonical exit: 16 Oct 2025 (T+90)
5,000 shares@ US$2.825.0% of flowCommon StockSEC:0001493152-25-004108:0
Canonical exit: 28 Apr 2025 (T+90)
5,000 shares@ US$3.095.3% of flowCommon StockSEC:0001493152-24-029191:0
Canonical exit: 24 Oct 2024 (T+90)
10,000 shares@ US$3.6312.4% of flowCommon StockSEC:0001493152-24-010060:0
Canonical exit: 13 Jun 2024 (T+90)
39,473 shares0Common StockSEC:0001062993-22-015132:0
19,000 shares@ US$4.3325.9% of flowCommon StockSEC:0001493152-21-017817:0
Canonical exit: 21 Oct 2021 (T+90)
20,000 shares@ US$3.9024.5% of flowCommon StockSEC:0001493152-21-017005:0
Canonical exit: 13 Oct 2021 (T+90)
10,000 shares@ US$0.82100.0% of flowCommon StockSEC:0001192482-21-000422:0
Canonical exit: 9 Aug 2021 (T+90)
12 of 12 declarations
